Literature DB >> 33336713

Suppression of microRNA-101 attenuates hypoxia-induced myocardial H9c2 cell injury by targeting DIMT1-Sp1/survivin pathway.

Z-X Guo1, F-Z Zhou, W Song, L-L Yu, W-J Yan, L-H Yin, H Sang, H-Y Zhang.   

Abstract

The article "Suppression of microRNA-101 attenuates hypoxia-induced myocardial H9c2 cell injury by targeting DIMT1-Sp1/survivin pathway, by Z.-X. Guo, F.-Z. Zhou, W. Song, L.-L. Yu, W.-J. Yan, L.-H. Yin, H. Sang, H.-Y. Zhang, published in Eur Rev Med Pharmacol Sci 2018; 22 (20): 6965-6976-DOI: 10.26355/eurrev_201810_16167-PMID: 30402863" has been withdrawn from the authors due to some inaccuracies. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16167.

Entities:  

Year:  2020        PMID: 33336713     DOI: 10.26355/eurrev_202012_23952

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  1 in total

1.  Relationship between Peripheral Blood miR-181c, miR-101, and Cognitive Impairment in Patients with Diabetes Mellitus Complicated with Acute Stroke.

Authors:  Mengxian Shu; Chunhui Xiang
Journal:  Emerg Med Int       Date:  2022-09-30       Impact factor: 1.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.